Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research
- PMID: 29654098
- PMCID: PMC5901889
- DOI: 10.1161/CIRCGEN.118.002178
Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research
Abstract
The National Institutes of Health have made substantial investments in genomic studies and technologies to identify DNA sequence variants associated with human disease phenotypes. The National Heart, Lung, and Blood Institute has been at the forefront of these commitments to ascertain genetic variation associated with heart, lung, blood, and sleep diseases and related clinical traits. Genome-wide association studies, exome- and genome-sequencing studies, and exome-genotyping studies of the National Heart, Lung, and Blood Institute-funded epidemiological and clinical case-control studies are identifying large numbers of genetic variants associated with heart, lung, blood, and sleep phenotypes. However, investigators face challenges in identification of genomic variants that are functionally disruptive among the myriad of computationally implicated variants. Studies to define mechanisms of genetic disruption encoded by computationally identified genomic variants require reproducible, adaptable, and inexpensive methods to screen candidate variant and gene function. High-throughput strategies will permit a tiered variant discovery and genetic mechanism approach that begins with rapid functional screening of a large number of computationally implicated variants and genes for discovery of those that merit mechanistic investigation. As such, improved variant-to-gene and gene-to-function screens-and adequate support for such studies-are critical to accelerating the translation of genomic findings. In this White Paper, we outline the variety of novel technologies, assays, and model systems that are making such screens faster, cheaper, and more accurate, referencing published work and ongoing work supported by the National Heart, Lung, and Blood Institute's R21/R33 Functional Assays to Screen Genomic Hits program. We discuss priorities that can accelerate the impressive but incomplete progress represented by big data genomic research.
Keywords: exome; gene expression; genetic techniques; genome-wide association studies; human genetics.
© 2018 American Heart Association, Inc.
Similar articles
-
Genome analysis and knowledge-driven variant interpretation with TGex.BMC Med Genomics. 2019 Dec 30;12(1):200. doi: 10.1186/s12920-019-0647-8. BMC Med Genomics. 2019. PMID: 31888639 Free PMC article.
-
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits.Pharmacogenomics. 2013 Mar;14(4):413-24. doi: 10.2217/pgs.13.36. Pharmacogenomics. 2013. PMID: 23438888 Review.
-
Genomic Analysis in the Age of Human Genome Sequencing.Cell. 2019 Mar 21;177(1):70-84. doi: 10.1016/j.cell.2019.02.032. Cell. 2019. PMID: 30901550 Free PMC article. Review.
-
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.Pharmacogenomics. 2004 Oct;5(7):952-1004. doi: 10.1517/14622416.5.7.949. Pharmacogenomics. 2004. PMID: 15469413
-
Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era.Circ Cardiovasc Genet. 2008 Oct;1(1):51-7. doi: 10.1161/CIRCGENETICS.108.813337. Circ Cardiovasc Genet. 2008. PMID: 20031542 Free PMC article. Review.
Cited by
-
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.Cell Stem Cell. 2021 Dec 2;28(12):2076-2089.e7. doi: 10.1016/j.stem.2021.08.006. Epub 2021 Sep 15. Cell Stem Cell. 2021. PMID: 34525346 Free PMC article.
-
PhenomeXcan: Mapping the genome to the phenome through the transcriptome.Sci Adv. 2020 Sep 10;6(37):eaba2083. doi: 10.1126/sciadv.aba2083. Print 2020 Sep. Sci Adv. 2020. PMID: 32917697 Free PMC article.
-
Identifying adaptive alleles in the human genome: from selection mapping to functional validation.Hum Genet. 2021 Feb;140(2):241-276. doi: 10.1007/s00439-020-02206-7. Epub 2020 Jul 29. Hum Genet. 2021. PMID: 32728809 Review.
-
Applying Functional Genomics to Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2018 Dec;15(Suppl 4):S239-S242. doi: 10.1513/AnnalsATS.201808-530MG. Ann Am Thorac Soc. 2018. PMID: 30759001 Free PMC article. Review.
-
Molecular networks in Network Medicine: Development and applications.Wiley Interdiscip Rev Syst Biol Med. 2020 Nov;12(6):e1489. doi: 10.1002/wsbm.1489. Epub 2020 Apr 19. Wiley Interdiscip Rev Syst Biol Med. 2020. PMID: 32307915 Free PMC article. Review.
References
-
- Musunuru K, Ingelsson E, Fornage M, Liu P, Murphy AM, Newby LK, et al. The expressed genome in cardiovascular diseases and stroke: refinement, diagnosis, and prediction: a scientific statement from the American Heart Association. Circ Cardiovasc Genet. 2017;10:e000037. doi: 10.1161/HCG.0000000000000037. - DOI - PubMed
-
- GTEx Consortium. Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; et al. Genetic effects on gene expression across human tissues. Nature. 2017;550:204–213. doi: 10.1038/nature24277. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials